Adrenal cortex and Simulect drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adrenal cortex (adrenal extract) and Simulect (basiliximab). Common drug interactions include acute graft versus host disease among females and post transplant distal limb syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Adrenal cortex and Simulect. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Adrenal cortex?

Adrenal cortex has active ingredients of adrenal extract. eHealthMe is studying from 88 Adrenal cortex users. Check the latest studies of Adrenal cortex.

What is Simulect?

Simulect has active ingredients of basiliximab. eHealthMe is studying from 3,861 Simulect users. Check the latest studies of Simulect.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

11 people who take Adrenal cortex and Simulect together, and have interactions are studied.

Adrenal cortex and Simulect drug interactions.

What are the common drug interactions of Adrenal Cortex and Simulect, by gender? *:

female:

  1. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Bacteraemia (presence of bacteria in the blood)
  5. Bone marrow failure
  6. Diarrhoea
  7. Exfoliative rash (scaly red generalized skin rash)
  8. General physical health deterioration (weak health status)
  9. Hypotension (abnormally low blood pressure)
  10. Pain

male:

  1. Post transplant distal limb syndrome
  2. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  3. Bacterial infection
  4. Bile duct stenosis (abnormal narrowing of the common bile duct)
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Cholangitis (infection of the bile duct)
  7. Cytomegalovirus infection
  8. Drug ineffective
  9. Hepatic failure (liver failure)
  10. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)

What are the common drug interactions of Adrenal Cortex and Simulect, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  2. Bacteraemia (presence of bacteria in the blood)
  3. Diarrhoea
  4. General physical health deterioration (weak health status)
  5. Rash generalised (rash on most of body parts)
  6. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  7. Alanine aminotransferase increased
  8. Aspartate aminotransferase increased
  9. Bone marrow failure
  10. Exfoliative rash (scaly red generalized skin rash)

40-49:

  1. Cytomegalovirus infection
  2. Hepatic failure (liver failure)
  3. Hepatitis (inflammation of the liver)
  4. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  5. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

50-59:

  1. Ureteric stenosis (abnormal narrowing or contraction of a duct or canal)

60+:

  1. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  2. Immunosuppressant drug level increased
  3. Metastases to liver (cancer spreads to liver)

What are the existing conditions these people have? *

  1. Renal And Pancreas Transplant Rejection: 3 people, 27.27%
  2. Immunodeficiency Disorders: 2 people, 18.18%
  3. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Adrenal cortex and Simulect?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adrenal cortex and Simulect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adrenal cortex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simulect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adrenal cortex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simulect and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on adrenal extract and basiliximab (the active ingredients of Adrenal cortex and Simulect, respectively), and Adrenal cortex and Simulect (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: